One of One Hundred in Operation Worldwide:

MR-Linac

In keeping with its commitment to bring the most advanced cancer treatments close to home for New Jersey residents, RWJBarnabas Health together with Rutgers Cancer Institute, are now offering the Elekta Unity MR-Linac, a highly advanced imaging and radiation oncology technology, at the Jack & Sheryl Morris Cancer Center. The MR-Linac at the Morris Cancer Center will be one of only 100 operational worldwide and one of just two in New Jersey.

Transplant & Cellular Therapies for Blood Disorders

Rutgers Cancer Institute in collaboration with Robert Wood Johnson University Hospital, are celebrating the 30th anniversary of the Transplant and Cellular Therapy Program, which has provided life-saving care to patients since 1995. Our Program is the only one in New Jersey offered at an NCI-designated Comprehensive Cancer Center. Patients benefit from state-of-the-art therapies, individualized treatment plans, and access to groundbreaking clinical trials. 

7 Tips from a Pediatric Cancer Doctor to Help Your Child Have a Healthy School Year

For children and teens continuing school during cancer treatment, the start of the school year is a great time to bring a sense of normalcy back into their lives. It is also important to embrace healthy habits to reduce the likelihood of health-related challenges. Peter Cole, MD, chief of Pediatric Hematology/Oncology at Rutgers Cancer Institute and RWJBarnabas Health, shares tips for a healthy start to a new school year.





Gynecologic Cancers: What Every Woman Should Know



In honor of Gynecologic Cancer Awareness Month, we are shedding light on Ovarian Cancer, one of the leading causes of cancer deaths among women. According to the American Cancer Society, more than 20,000 women will receive a new diagnosis of ovarian cancer in 2025. Dr. Ruth Stephenson, a gynecologic oncologist from Rutgers Cancer Institute and RWJBarnabas Health, addresses five frequently asked questions about the symptoms, diagnosis, and ways to reduce your risk for ovarian cancer.